Tango Therapeutics Inc (TNGX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $4.32B
Last updated: Nov 17, 2026 at 4:15 PM ET
Tango Therapeutics Inc (TNGX) Stock Chart
Tango Therapeutics (TNGX) has a latest price of $22.11 on Nov 17, 2026, 35.7% below its 52-week high of $34.39. Its price rose 170.6% over the past 12 months. The month-end price rose 76.9% over the 5 years through Oct 2026, a compound annual rate of 12.1%.
Price Chart
From Sep 2020 to Oct 2026, its highest month-end close was $31.26 in Jun 2026 and its lowest $1.37 in Mar 2025, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart TNGX with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for TNGX.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 12.3%, and over 6 months it rose 8.9%. The month-end price rose 170.5% over the 3 years through Oct 2026, a compound annual rate of 39.3%.
| Period | Change |
|---|---|
| 1 month | -6.0% |
| 3 months | -12.3% |
| 6 months | +8.9% |
| 12 months | +170.6% |
| 12 months, with dividends | +170.6% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +170.5% | +39.3% |
| 5 years | +76.9% | +12.1% |
Price by Year
Its best calendar year was 2025, when the price rose 186.7%, and its weakest was 2024, when it fell 68.8%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $22.72 | +156.4% |
| 2025 | $8.86 | +186.7% |
| 2024 | $3.09 | -68.8% |
| 2023 | $9.90 | +36.6% |
| 2022 | $7.25 | -33.7% |
| 2021 | $10.94 | -4.4% |
Trading Range
The price is 6.1% below its 50-day average of $23.55 and 3.9% below its 200-day average of $23.01.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $22.11 | |
| 52-week high | $34.39 | -35.7% |
| 52-week low | $7.83 | +182.4% |
| 50-day average | $23.55 | -6.1% |
| 200-day average | $23.01 | -3.9% |
Price Risk
Over 3 years, its largest fall from a peak was 91.5%.
| Measure | Value |
|---|---|
| 1-year beta | 1.68 |
| Largest fall, 1 year | -36.6% |
| Largest fall, 3 years | -91.5% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About TNGX
What is TNGX's 1-year price change?
Tango Therapeutics's price rose 170.6% over the past 12 months. With dividends included, the 12-month total return was 170.6%.
What is TNGX's 5-year price change?
Tango Therapeutics's month-end price rose 76.9% over the 5 years through Oct 2026, a compound annual rate of 12.1%. These figures leave out dividends.
What is TNGX's 52-week high and low?
Tango Therapeutics's 52-week high is $34.39 and its 52-week low is $7.83. Its latest price of $22.11 on Nov 17, 2026 is 35.7% below the high.
What is TNGX's beta?
Tango Therapeutics's 1-year beta against the S&P 500 is 1.68, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 36.6%.
Is the TNGX chart free?
Yes. Advanced Charting for TNGX is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
TNGX pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors